Clinical Trials Logo

Hyperglycemia clinical trials

View clinical trials related to Hyperglycemia.

Filter by:

NCT ID: NCT03482154 Completed - Hyperglycemia Clinical Trials

Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population

Start date: September 6, 2016
Phase:
Study type: Observational

This is a retrospective chart review of patients who underwent a hematopoietic stem cell transplant (HSCT) between 1994 and 2016 to evaluate incidence of malglycemia and the relationship to specific outcomes.

NCT ID: NCT03469869 Completed - Obesity Clinical Trials

Effects of Balanced and Sustainable Diet Application for Insulin Resistance and Inflammation Marker of Obese People

Start date: March 16, 2018
Phase: N/A
Study type: Interventional

This study evaluates the effect of balanced and sustainable diet application on fat composition, insulin resistance and inflammation marker in obese people. Intervention: Obese subject will receive intervention on balanced and sustainable diet application Control: Obese subject will receive a balanced diet application only

NCT ID: NCT03469492 Completed - Clinical trials for Hyperglycaemia (Diabetic)

Investigating the Role of the Polyol Pathway in the Central Nervous System Production of Fructose

Start date: January 18, 2018
Phase: Early Phase 1
Study type: Interventional

To investigate whether longer-term improvement of glycemic control in poorly controlled diabetes patients with a 12-week intensified insulin treatment regimen will lead to decreased polyol pathway activity.

NCT ID: NCT03461510 Completed - Obesity Clinical Trials

Type 2 Diabetes and the Brain in Adolescents

Start date: December 5, 2017
Phase: N/A
Study type: Interventional

This study evaluates differences in brain function and cognitive performance in adolescents with type 2 diabetes (T2D) compared to non diabetic controls (both obese and lean) and correlates these changes with obesity, insulin resistance, and glycemic control in youth with T2D.

NCT ID: NCT03414892 Completed - Clinical trials for Type 2 Diabetes Mellitus

Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus

Start date: January 3, 2018
Phase: Phase 1
Study type: Interventional

This is a phase I placebo-controlled study to assess safety, tolerability, pharmacokinetics and pharmacodynamics of Globalagliatin Hydrochloride (SY-004) after Multiple Ascending Doses in patients with Type 2 Diabetes Mellitus (T2DM).

NCT ID: NCT03412617 Completed - Obesity Clinical Trials

Diets, Metabolic Profile and Gut Microbiota Among Indonesian Women in Minangkabau and Sundanese-ethnic Community

Start date: August 22, 2016
Phase: N/A
Study type: Observational

Many provinces in Indonesia have some well known traditional foods that are widely consumed, but it remains unknown whether traditional ethnic dietary patterns can confirm healthy diets. High quality diet is associated with reduced risk of metabolic diseases and modulated gut microbiota. Moreover, the relationship between dietary quality and microbiota, a potential mediator of metabolic disease, has not been studied.

NCT ID: NCT03400774 Completed - Clinical trials for Postprandial Hyperglycemia

The Acute Effect of Moderate Intensity Stair-Climbing on Postprandial Blood Glucose

Start date: March 23, 2016
Phase: N/A
Study type: Interventional

This study aims to investigate the effect of moderate intensity stair-climbing bouts of various durations on postprandial blood glucose. Participants will perform a standard oral glucose tolerance test (OGTT) using 75g of dextrose and with fingerstick blood glucose measurements at baseline and every 15 minutes after consuming the drink for one hour. On separate subsequent visits, participants will perform the same OGTT combined with three stair-climbing bouts lasting 1, 3, and 10 minutes starting 27, 25, and 18 minutes respectively after finishing the drink. Participants performed maximal aerobic capacity (VO2max) using a ramp treadmill test in order to assess the relative intensity of each stairclimbing trial.

NCT ID: NCT03375398 Completed - Clinical trials for Postprandial Hyperglycemia

Determination of the PPG and Insulin Responses of Rice Alone and Rice Consumed With Sugardown™

Start date: March 2011
Phase: N/A
Study type: Interventional

This study was a partly controlled laboratory-based study comparing the short-term postprandial blood glucose and insulin responses produced by 3 test meals containing white rice alone or with SUGARDOWN™ (Galactomannan) in overweight adults.

NCT ID: NCT03374501 Completed - Clinical trials for Postprandial Hyperglycemia

Determination of the GI and II Values of Soft Drink and Soft Drink With Sugardown™

Start date: November 2014
Phase: N/A
Study type: Interventional

This study was a partly controlled laboratory-based study comparing the glycemic and insulinemic indices of 3 test meals containing soft drink alone or with SUGARDOWN™ (Galactomannan) in overweight adults.

NCT ID: NCT03356457 Completed - Clinical trials for Hyperglycaemia (Diabetic)

Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes

Start date: November 30, 2017
Phase: Early Phase 1
Study type: Interventional

To determine the effect of re-activation of brain glucose metabolism induced by dichloroacetate (DCA) on cognitive function and counterregulatory hormone responses in patients with type 1 diabetes (T1DM) with recurrent hypoglycemia.